Search

Search Constraints

You searched for: Author/Creator Ma, C

Search Results

2. DOP39 Safety of combination biologic and anti-rejection therapy post-liver transplantation in patients with inflammatory bowel disease: London Ontario experience. (25th January 2019)

3. A130 SAFETY OF COMBINATION BIOLOGIC AND ANTI-REJECTION THERAPY POST-LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: LONDON ONTARIO EXPERIENCE. (15th March 2019)

5. A17 THE NEUROPEPTIDE VIP REGULATES INTESTINAL IMMUNITY THROUGH MODULATING THE ACTIVATION AND RECRUITMENT OF GROUP 3 INNATE LYMPHOID CELLS. (15th March 2019)

10. P703 Clinical, radiographic and endoscopic remission with vedolizumab treatment in Crohn's disease. (16th January 2018)